Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing

Current evidence suggests that botulinum neurotoxins (BoNTs) A1 and B1, given locally into peripheral tissues such as skin, muscles, and joints, alter nociceptive processing otherwise initiated by inflammation or nerve injury in animal models and humans. Recent data indicate that such locally delive...

Full description

Bibliographic Details
Main Authors: Sabine Pellett, Tony L. Yaksh, Roshni Ramachandran
Format: Article
Language:English
Published: MDPI AG 2015-11-01
Series:Toxins
Subjects:
Online Access:http://www.mdpi.com/2072-6651/7/11/4519